← Back to Search

Intervention for Hepatitis C

N/A
Recruiting
Led By Meghan D Morris, MPH, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up point of hcv treatment initiation up to 3 years
Awards & highlights

Study Summary

This trial is studying a new intervention to see if it can help more people with hepatitis C who use drugs to start treatment. It is a randomized controlled study, which means some participants will receive the intervention

Who is the study for?
This trial is for adults who have used injection drugs in the past month, share their injecting activities with a primary partner, and have been diagnosed with hepatitis C at a community-based clinical site.Check my eligibility
What is being tested?
The study is testing a 'Partner Navigation Intervention' to see if it helps people who inject drugs start treatment for hepatitis C. It's an RCT, meaning participants are randomly assigned to either receive the intervention or not.See study design
What are the potential side effects?
Since this trial focuses on behavioral intervention rather than medication, there may be no direct medical side effects. However, participants might experience stress or emotional discomfort.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~point of hcv treatment initiation up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and point of hcv treatment initiation up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention efficacy
Secondary outcome measures
Change in Partner Support (Intervention mechanism)
HCV Treatment Completion
Sustained Virologic Response at 12 weeks post treatment completion (SVR12)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
In addition to standard HCV results disclosure for the comparator arm, intervention participants will have two counseling sessions: Session 1: Immediately after HCV results disclosure, a staff-facilitated session with the index to (1) Establish HCV Treatment Goals, fostering commitment, and (2) Engage the Injecting Partner, identifying ways to support treatment initiation. Session 2: One week later, involving both the index and injecting partner, to (1) Enhance Partner Support with specific strategies for HCV treatment initiation and (2) Collaborative Navigation Mapping, using a "navigation map" tool. By Session 2's end, both will have a completed navigation map, a visual guide for the HCV treatment journey. Both sessions stress communication and dyadic coordination. The "navigation map" tool ensures a personalized plan for the index's treatment initiation and the partner's supportive navigator role.
Group II: ControlActive Control1 Intervention
Standard of care HCV disclosure. This staff-facilitated session follows the California HIV/HCV test counselor certification protocol with the Index alone.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,481 Total Patients Enrolled
46 Trials studying Hepatitis C
22,288 Patients Enrolled for Hepatitis C
University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,238,305 Total Patients Enrolled
16 Trials studying Hepatitis C
3,863 Patients Enrolled for Hepatitis C
Meghan D Morris, MPH, PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new patients currently being enrolled in this ongoing medical study?

"As per clinicaltrials.gov, the current status of this trial indicates that it is not actively seeking participants. The initial posting date was on December 20th, 2023 and the most recent update occurred on December 12th, 2023. It's important to note that although this particular study is not accepting candidates at present, there are currently 252 other ongoing studies that are open for enrollment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
2024. "Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06179498.
All > Hepatitis C > Sacramento
~167 spots leftby Jul 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top